DHR Health Expands Cancer Support Through 2026 Monthly Group Meetings

Translate to Spanish or other 102 languages!

These free support groups are offered in both English and Spanish and are held monthly at 6:00 p.m. at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado Ave in Edinburg. Image for illustration purposes
These free support groups are offered in both English and Spanish and are held monthly at 6:00 p.m. at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado Ave in Edinburg. Image for illustration purposes
- Advertisement -

EDINBURG, Texas – The DHR Health Oncology Institute will continue hosting their monthly cancer patient and family support group throughout 2026 to help connect cancer patients and their families with others who may benefit from shared connection, education, and encouragement.

These free support groups are offered in both English and Spanish and are held monthly at 6:00 p.m. at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado Ave in Edinburg. Each meeting is moderated by an oncology professional who provides a confidential, welcoming space for patients and loved ones to share experiences, ask questions, and find comfort in a supportive community.

Courtesy image

“Our goal with these monthly support groups is to continue growing the program so more patients and families feel supported not just clinically, but emotionally and socially as well,” said Anabel Arellano, Director of Patient Relations. “Cancer impacts both patients and their families, and it’s important for them to have a place where they feel heard, supported, and reminded that they are not alone on this journey.”

- Advertisement -

The DHR Health Oncology Institute invites you to join their first support group of the year, which is scheduled for January 29, 2026. Additional 2026 meeting dates include February 26, March 26, April 30, May 28, June 25, July 30, August 27, September 24, October 28, November 18, and December 16.

Community members interested in attending are encouraged to join. For more information, call the DHR Health Oncology Institute at (956) 362-2250.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -